When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Puma Biotechnology (NASDAQ:PBYI) announces that China's National Medical Products Administration has approved Nerlynx (neratinib) for the extended adjuvant treatment of adult patients with early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer, following adjuvant therapy with trastuzumab (branded as Herceptin by Roche).
More news on: Puma Biotechnology, Inc., Healthcare stocks news, Stocks on the move,